Return to Statistics Toolbox

Volcano Plot analysis for Study ST000661

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:1 Month | Treatment:Ornish | Type:Clinical (10)
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:1 Month | Treatment:Southbeach | Type:Clinical (10)
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:6 Months | Treatment:Ornish | Type:Clinical (10)
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:6 Months | Treatment:Southbeach | Type:Clinical (10)
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:Baseline | Treatment:Ornish | Type:Clinical (10)
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:Baseline | Treatment:Southbeach | Type:Clinical (10)
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:0 Days | Treatment:Baseline | Type:Preclinical (5)
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Gainer (ad lib) | Type:Preclinical (1)
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Loser (40% DER) | Type:Preclinical (1)
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Gainer (ad lib) | Type:Preclinical (1)
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Loser (40% DER) | Type:Preclinical (1)
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Gainer (ad lib) | Type:Preclinical (1)
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Loser (40% DER) | Type:Preclinical (1)
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Gainer (ad lib) | Type:Preclinical (2)
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Loser (40% DER) | Type:Preclinical (2)
Sample type:Plasma | Sample_Source:POOLED | Species:Homo sapiens | Study:POOLED | Time_Point:POOLED | Treatment:POOLED | Type:POOLED (1)
Sample type:Plasma | Sample_Source:POOLED | Species:Rattus | Study:POOLED | Time_Point:POOLED | Treatment:POOLED | Type:POOLED (1)
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:0 Days | Treatment:Baseline | Type:Preclinical (5)
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Gainer (ad lib) | Type:Preclinical (1)
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Loser (40% DER) | Type:Preclinical (1)
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Gainer (ad lib) | Type:Preclinical (1)
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Loser (40% DER) | Type:Preclinical (1)
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Gainer (ad lib) | Type:Preclinical (1)
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Loser (40% DER) | Type:Preclinical (1)
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Gainer (ad lib) | Type:Preclinical (2)
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Loser (40% DER) | Type:Preclinical (2)
Sample type:Tissues | Sample_Source:POOLED | Species:Rattus | Study:POOLED | Time_Point:POOLED | Treatment:POOLED | Type:POOLED (1)
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Group by metabolite classification:    Use:
Maximum # of (most significant) metabolites per class to use in pvalue group calculation:
Analysis:Combine data for all analyses?:     

  logo